Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Overview of attention for article published in New England Journal of Medicine, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 71 news outlets
blogs: 7 blogs
twitter: 554 X users
facebook: 4 Facebook pages
wikipedia: 1 Wikipedia page

reddit: 4 Redditors
video: 6 YouTube creators
guideline: 7 clinical guideline sources
bluesky: 12 Bluesky users
podcasts: 13 podcasts

Readers on

mendeley: 567 Mendeley

So far, Altmetric has seen 14 Bluesky posts from 12 Bluesky users, with an upper bound of 40,689 followers.

RP @nejm.org: NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: ne…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 10 additional Bluesky posts.